Selected Tag: Aurobindo Pharma
Selected Tag: Aurobindo Pharma

Aurobindo Pharma’s Telangana API Unit Gets Five FDA Observations

BasisPoint Insight

September 2, 2025 at 10:27 AM IST


Aurobindo Unit CuraTeQ Gets UK Approval for Breast Cancer Biosimilar

BasisPoint Insight

August 28, 2025 at 7:39 AM IST


Aurobindo Pharma Denies Definitive Move on Zentiva Deal

BasisPoint Insight

August 21, 2025 at 2:45 AM IST


Aurobindo Pharma Extends Deadline For 26% Stake Buy In Solar Firm

BasisPoint Insight

July 1, 2025 at 10:38 AM IST


Aurobindo Pharma's Unit CuraTeQ Gets UK Nod For Third Biosimilar

BasisPoint Insight

June 26, 2025 at 6:56 AM IST


UK Regulator Clears CuraTeQ’s Filgrastim Biosimilar Zefylti

BasisPoint Insight

May 14, 2025 at 9:35 AM IST


Aurobindo’s Eugia Pharma Gets US FDA Nod To Launch Dasatinib Tablets

BasisPoint Insight

April 24, 2025 at 5:10 PM IST


US FDA Issues 11 Observations For Aurobindo Pharma's US Plant

BasisPoint Insight

April 12, 2025 at 4:58 AM IST